Literature DB >> 17116444

Oral antibiotic therapy of serious systemic infections.

Burke A Cunha1.   

Abstract

Traditionally, antibiotics have been administered intravenously (IV) for serious systemic infections. As more potent oral antibiotics were introduced, and their pharmacokinetic aspects studied, orally administered antibiotics have been increasingly used for serious systemic infections. Antibiotics ideal for oral administration are those that have the appropriate spectrum, high degree of activity against the presumed or known pathogen, and have good bioavailability. Oral antibiotics with high bioavailability, that is > or = 90% absorbed, achieve serum/tissue concentrations comparable to IV administered antibiotics at the same dose. The popularity of "IV to PO switch therapy" is possible because of the availability of many potent oral antibiotics with high bioavailability. Initial IV therapy is appropriate in patients who are in shock/have impaired intestinal absorption, but after clinical defervescence, completion of therapy should be accomplished with oral antibiotics. As experience with "IV to PO switch therapy" has accumulated, confidence in oral antimicrobics for therapy of serious systemic infections has continued to increase. The trend in treating serious systemic infections entirely with oral antimicrobial therapy will continue, and is clearly the wave of the future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116444     DOI: 10.1016/j.mcna.2006.07.009

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  13 in total

1.  An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant Gram-negative uropathogens: the importance of urinary antibiotic concentrations and urinary pH.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-09       Impact factor: 3.267

2.  Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs).

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-18       Impact factor: 3.267

Review 3.  Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.

Authors:  B A Cunha; J Baron; C B Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-17       Impact factor: 3.267

4.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

5.  Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates.

Authors:  Ashraf El Houfi; Nadeem Javed; Caitlyn T Solem; Cynthia Macahilig; Jennifer M Stephens; Nirvana Raghubir; Richard Chambers; Jim Z Li; Seema Haider
Journal:  Infect Drug Resist       Date:  2015-06-18       Impact factor: 4.003

6.  Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in Europe.

Authors:  Dilip Nathwani; Christian Eckmann; Wendy Lawson; Caitlyn T Solem; Shelby Corman; Jennifer M Stephens; Cynthia Macahilig; Damien Simoneau; Richard Chambers; Jim Z Li; Seema Haider
Journal:  BMC Infect Dis       Date:  2014-09-02       Impact factor: 3.090

7.  Oral versus IV treatment for catheter-related bloodstream infections.

Authors:  Burke A Cunha
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

8.  Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin.

Authors:  Jennifer M Stephens; Xin Gao; Dipen A Patel; Bram G Verheggen; Ahmed Shelbaya; Seema Haider
Journal:  Clinicoecon Outcomes Res       Date:  2013-09-16

Review 9.  Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review.

Authors:  Awad Al-Omari; D William Cameron; Craig Lee; Vicente F Corrales-Medina
Journal:  BMC Infect Dis       Date:  2014-03-13       Impact factor: 3.090

Review 10.  A case study on Staphylococcus aureus bacteraemia: available treatment options, antibiotic R&D and responsible antibiotic-use strategies.

Authors:  Annelie A Monnier; Evelina Tacconelli; Christine Årdal; Marco Cavaleri; Inge C Gyssens
Journal:  JAC Antimicrob Resist       Date:  2020-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.